Reevaluating predictive factors for treatment success in therapy with OnabotulinumtoxinA for iOAB in a real-world study.

Nestler S, Alloussi S, Grüne B, Carl N, Garm J, Neisius A

Open source

DOI
10.1007/s11255-026-05423-7
Published
2026 Oct 5
Container
International urology and nephrology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11255-026-05423-7,
  title = {Reevaluating predictive factors for treatment success in therapy with OnabotulinumtoxinA for iOAB in a real-world study.},
  author = {Nestler S and Alloussi S and Grüne B and Carl N and Garm J and Neisius A},
  year = {2026},
  journal = {International urology and nephrology},
  doi = {10.1007/s11255-026-05423-7},
  url = {https://doi.org/10.1007/s11255-026-05423-7}
}

RIS

TY  - JOUR
TI  - Reevaluating predictive factors for treatment success in therapy with OnabotulinumtoxinA for iOAB in a real-world study.
AU  - Nestler S
AU  - Alloussi S
AU  - Grüne B
AU  - Carl N
AU  - Garm J
AU  - Neisius A
PY  - 2026
JO  - International urology and nephrology
DO  - 10.1007/s11255-026-05423-7
UR  - https://doi.org/10.1007/s11255-026-05423-7
ER  - 

APA

S, N., S, A., B, G., N, C., J, G., & A, N. (2026). Reevaluating predictive factors for treatment success in therapy with OnabotulinumtoxinA for iOAB in a real-world study.. International urology and nephrology. https://doi.org/10.1007/s11255-026-05423-7

Source records